International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) criteria are a key element by which the choice of systemic treatment is decided. However, heterogeneity may exist among IMDC risk categories. The first site of metastatic disease occurrence is related to overall survival. The addition of this variable to the others within the recognized IMDC score improves prognosis prediction.
Massari F., Di Nunno V., Guida A., Costa Silva C.A., Derosa L., Mollica V., et al. (2021). Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study. CLINICAL GENITOURINARY CANCER, 19(1), 32-40 [10.1016/j.clgc.2020.06.003].
Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study
Massari F.;Di Nunno V.;Guida A.;Derosa L.;Mollica V.;Brandi G.;
2021
Abstract
International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) criteria are a key element by which the choice of systemic treatment is decided. However, heterogeneity may exist among IMDC risk categories. The first site of metastatic disease occurrence is related to overall survival. The addition of this variable to the others within the recognized IMDC score improves prognosis prediction.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
